Market Place
Sourcing Support
EG 427 Treats First Patient With EG110A For Neurogenic Bladder
27 Feb 2025 //
GLOBENEWSWIRE
EG 427 Raises €27M In Series B For Clinical Study & Platform Expansion
20 Feb 2025 //
GLOBENEWSWIRE
1st gene therapy for prevalent neurology pathologies receives FDA IND clearance
24 Jun 2024 //
GLOBENEWSWIRE
EG427 Announces New Preclinical Results from Multiple Studies of EG110A
04 Jan 2024 //
GLOBENEWSWIRE
EG 427 announces final Series A closing, achieving €18M in total funds raised
13 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.